Impact of a laminar air flow portable device on post-intravitreal injection endophthalmitis rate.
Where this comes from
- Record sourced from PubMed, PMID 40866110.
- Also identified by DOI 10.1136/bjo-2025-327316.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Intravitreal injections (IVIs) are the most common outpatient procedure worldwide, yet no consensus exists regarding their optimal setting. This study analysed 101 976 IVIs performed between 2017 and 2023, comparing endophthalmitis rates before and after introducing a mobile laminar air flow (LAF) device in a clean room. The incidence of endophthalmitis decreased from 0.033% to 0.013%, a 63.2% risk reduction (Odds Ratio=0.368, p=0.04). These findings suggest that mobile LAF enhances air quality and reduces infection risk, offering a cost-effective, efficient alternative to operating theatres for IVIs.
Medical subject headings
- Endophthalmitis
- Intravitreal Injections
- Eye Infections, Bacterial
- Environment, Controlled